ChemoCentryx (CCXI) Financials

$10.33

$-0.03 (-0.24%)

As on 21-Oct-2026 14:30EDT

Market cap

$594 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	32.22	64.89	35.95	42.88
Cost of Revenue	--	--	0.30	--	70.28	62.74
Gross Profit	--	--	31.92	64.89	36.13	42.88
Operating Expenses	39.92	0.17	162.14	120.07	94.26	83.15
Operating Profit (EBIT)	-39.94	-0.17	-129.92	-55.18	-58.30	-40.27
Other Income	--	--	0.86	2.46	4.96	3.53
Profit before Tax	-134.22	0.38	-131.76	-55.36	-55.49	-37.97
Provision for Tax	--	--	--	--	--	--
Profit after Tax (Net Income)	-134.20	0.38	-131.76	-55.36	-55.49	-37.97
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-131.76	-55.36	-55.49	-37.97

Liabilities ($ Mln)	TTM	Dec-25	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	268.28	399.79	286.12	385.61	66.00	14.74
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	14.49	15.99	76.52	81.73	84.00	104.18
Current Liabilities	139.87	0.13	63.02	51.56	59.08	64.40
Total Liabilities	562.50	415.91	425.65	518.90	209.08	183.31

Assets ($ Mln)	TTM	Dec-25	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	421.02	414.85	156.48	77.33	34.72	1.93
Current Assets	1.61	1.06	269.18	441.57	174.36	181.38
Total Assets	562.50	415.91	425.65	518.90	209.08	183.31
Total Debt*	--	--	23.64	63.92	21.29	168.59
Net Current Assets	-138.25	0.93	206.16	390.01	115.28	116.99

Cashflow ($ Mln)	TTM	Dec-25	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-0.63	-75.62	-81.14	-70.12	16.44
Cash Flow from Investing Activities	--	-414.00	92.22	-282.36	-12.53	-53.07
Cash from Financing Activities	--	415.37	1.08	356.62	94.82	24.70
Net Cash Inflow / Outflow	--	--	17.68	-6.88	12.17	-11.93

Financials Ratios	TTM	Dec-25	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-2.41	0.01	-1.88	-0.84	-0.97	-0.76
Cash EPS ($)	--	0.01	-1.84	-0.83	-0.94	-0.75
Adjusted Book Value ($)	--	7.18	4.09	5.84	1.16	0.29
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.01	-1.08	-1.23	-1.23	0.33
Free Cash Flow per Share ($)	--	-0.01	-1.35	-1.46	-1.24	0.31

Profitability Ratios	TTM	Dec-25	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	--	-34.71	-20.62	-41.01	-21.42
ROE (%)	-40.17	--	-39.23	-24.51	-137.45	-80.77
ROA (%)	-47.70	--	-27.90	-15.21	-28.28	-20.38
EBIT Margin (%)	--	--	-417.24	-81.23	-148.36	-85.70
Net Margin (%)	--	--	-398.26	-82.19	-135.62	-81.82
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	--	-0.50	0.80	-0.16	-0.48
EBIT Growth (%)	--	--	-155.06	1.18	-45.17	-305.69
Net Profit Growth (%)	--	--	-138.01	0.24	-46.15	-312.59
EPS Growth (%)	--	--	-1.24	0.14	-0.28	-3.13
Book Value Growth (%)	7,895,814.75	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	--	-19.34	-73.83	-40.63	-14.37
Price / Book Value	--	--	8.91	10.60	34.16	37.01
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	--	-17.58	-71.54	-40.68	-14.82
Close Price ($)	17.45	--	36.41	61.92	39.55	10.91
High Price ($)	17.50	--	70.29	65.43	39.75	15.08
Low Price ($)	10.14	--	9.53	30.72	6.16	5.72
Market Cap ($ Cr)	593.76	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	--	0.08	0.17	0.32	11.44
Short term debt to equity ratio	--	--	0.07	0.02	0.02	--
Current Ratio	0.01	8.13	4.27	8.56	2.95	2.82
Quick Ratio	0.01	--	4.26	--	--	--
Interest Coverage	--	--	-49.89	-19.94	-24.82	-30.02

Operating Efficiency Ratios	TTM	Dec-25	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	1.28	0.26	0.49	4.80
Asset Turnover	--	--	0.07	0.18	0.18	0.23
Receivable days	--	--	3.29	0.97	11.35	226.38
Inventory Days	--	--	1,029.23	--	--	--
Payable days	--	--	11,865.18	--	6.49	6.89
Cash Conversion Cycle	--	--	-10,832.66	--	--	219.50

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.